CORE
🇺🇦Â
 make metadata, not war
Services
Research
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
2 research outputs found
Effects of Single-Dose BAY 59-7939 - An Oral, Direct Factor Xa Inhibitor - in Subjects with Extreme Body Weight.
Author
Dagmar Kubitza
Michael Becka
Michael Zuehlsdorf
Wolfgang Mueck
Publication venue
'American Society of Hematology'
Publication date
Field of study
No full text
Crossref
Rivaroxaban (BAY 59-7939) – an oral, direct Factor Xa inhibitor – has no clinically relevant interaction with naproxen
Author
Born GV
Dagmar Kubitza
+9Â more
Lind SE
Michael Becka
Michael Zuehlsdorf
Mielke CH
Moote C
Paiement GD
Rodgers RP
Turpie AGG
Wolfgang Mueck
Publication venue
Blackwell Publishing Ltd
Publication date
Field of study
No full text
What is already known about this subjec
Crossref
PubMed Central